Learn how AspenTech University can help organizations to navigate challenges and compete at the highest level with our end-to-end competency development curriculum. AspenTech University offers flexible, expert-led classes that teach the in-depth knowledge and skills required to fully apply AspenTech solutions. Learn by solving real-world problems through hands-on exercises.

Receive the AspenTech monthly webinars e-newsletter to stay up-to-date on the latest topics for industrial leaders, including:

Companies on their Pharma 4.0 journey need tools that foster compliance and are compatible with their existing hardware and digital ecosystem, so they can manage today’s dynamic environment. AspenTech’s flexible Manufacturing Execution Systems (MES) solution automates, guides and digitally records SOPs according to cGMP guidelines, reducing human error and minimizing risk of deviations.

View this interactive infographic to see how AspenTech’s transformative digital technologies are enabling pharma companies to boost efficiency and productivity and improve access to medicine.

GSK wanted to review the structure of its batch production record and associated workflows as part of a continuous improvement process. AspenTech was selected for this process due to integration with other solutions, such as Aspen InfoPlus.21® and GSK’s existing plant automation software (DCS). The pilot project was a resounding success, reducing order preparation time by 95% and record review time by over 50%. Read this case study to learn more.

Today’s pharmaceutical manufacturers face increasing pressure to deliver high-quality medicines quickly, efficiently and economically while complying with regulatory requirements and meeting sustainability goals. AspenTech’s Manufacturing Execution Systems (MES) solution digitally guides and records batch procedures in line with the ISPE’s Pharma 4.0 initiative, increasing production quality and reducing cycle time, cost and waste.

The pandemic heightened the need for agility and resiliency within the supply chain. Speed to market remains a top business imperative as we move into the next normal for pharma.

Speed to market remains a key driver for the digitalization of long-standing paper-based processes in drug manufacturing. Bottlenecks such as manual execution and review—all associated with bloated documentation—prevent companies from aligning with the FDA’s vision for advanced manufacturing to achieve continuous improvement. Manufacturers like GlaxoSmithKline (GSK) are embracing Pharma 4.0 and paperless technologies to help bring quality medicines to patients more quickly.

How are you keeping up with growing demand? Digitalize batch execution and records with Aspen Production Execution Manager™ to accelerate time-to-market with accuracy while maintaining regulatory compliance.

Accelerate time-to-market by executing work orders faster, accurately and consistently with Aspen Production Execution Manager™